India to Uzbekistan: Extract Export Trade Route

The India to Uzbekistan Extract corridor is one of India's established pharmaceutical export routes, with 23 shipments documented worth a combined $344.3K USD. The route is dominated by PANACEA BIOTEC PHARMA LIMITED, which alone accounts for roughly 44% of all export value, reflecting the consolidated nature of India's extract manufacturing sector.

Across 5 active suppliers, the average shipment value stands at $15.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during October–December, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 28.5%, placing it at rank #19 among India's top extract export destinations globally.

On the import side, key buyers of Indian extract in Uzbekistan include LLC VISTTA MEDICARE, LLC SERENE PHARMA, LLC GANGA HEALTHCARE and 4 others. LLC VISTTA MEDICARE is the single largest importer with 12 shipments valued at $123.8K USD.

India's extract exports to Uzbekistan are driven primarily by a handful of large-scale manufacturers. PANACEA BIOTEC PHARMA LIMITED with 8 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Uzbekistan benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — PANACEA BIOTEC PHARMA LIMITED, NAXCUURE HEALTHCARE PRIVATE LIMITED, ISSHAAN HEALTHCARE PRIVATE LIMITED — together account for 94% of total trade value on this route. The average shipment value of $15.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as travrelax neo herbal cough syrup composition:each 10 mlcontains extract of:terminalia belerica 100mg. o/d as per invoice and travrelax herbal granules each 5g sachetcontains:mentha sylvestris 0.12% w/w extract of:- glycyrrhiza. o/d as per inv., suggesting that buyers in Uzbekistan tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, LLC VISTTA MEDICARE is the largest importer with 12 shipments worth $123.8K USD — representing 36% of all extract imports from India on this route. A total of 7 buyers are active on this corridor.